(Q44662293)

5 December 2017

title

Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression (English)

1 reference

5 December 2017

1 reference

1 reference

Martin M Katz

1

1 reference

5 December 2017

Janet L Tekell

2

1 reference

5 December 2017

Charles L Bowden

3

1 reference

5 December 2017

Steve Brannan

4

1 reference

5 December 2017

John P Houston

5

1 reference

5 December 2017

Nancy Berman

6

1 reference

5 December 2017

Alan Frazer

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

5 December 2017

published in

Neuropsychopharmacology

1 reference

5 December 2017

volume

29

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

566-579

1 reference

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

A diagnostic interview: the schedule for affective disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

5-Hydroxytryptamine pathways in anxiety and its treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Predictors of drug response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Video methodology for research in psychopathology and psychopharmacology: Rationale and application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Psychopharmacology and the etiology of psychopathologic states: are we looking in the right way?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Drug-induced actions on brain neurotransmitter systems and changes in the behaviors and emotions of depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Onset of response in relation to outcome in depressed outpatients with placebo and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Management of endogenous depressions using psychopharmacologic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Regional differences in the effects of forced swimming on extracellular levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Gender differences in treatment response to sertraline versus imipramine in chronic depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

The treatment of depressive states with G 22355 (imipramine hydrochloride).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Random-effects models for longitudinal data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Therapeutic advances: paroxetine for the treatment of social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Prediction of efficacy of antidepressant by 1-week test therapy in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Use of pattern analysis to identify true drug response. A replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF-REPORT RATINGS OF HOSPITALIZED DEPRESSIVES

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Individual differences in behavioral reactivity: correlation with stress-induced norepinephrine efflux in the hippocampus of Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

A microdialysis examination of serotonin release in the rat forebrain induced by behavioral/environmental manipulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Modulatory role of serotonin in neural information processing: implications for human psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

Serotonin selectively attenuates glutamate-evoked activation of noradrenergic locus coeruleus neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Paroxetine: a review.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

An inventory for assessing different kinds of hostility.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Early improvement as a predictor of response to amitriptyline and nortriptyline: a comparison of 2 patient samples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

The anti-anxiety and anti-agitation effects of paroxetine in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

How fast are antidepressants?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Single-unit and physiological analyses of brain norepinephrine function in behaving animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

A multi-vantaged approach to measurement of behavioral and affect states for clinical and psychobiological research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

The timing, specificity and clinical prediction of tricyclic drug effects in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

The long-term outcome of depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

The advantages of paroxetine in different subgroups of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Identification of true drug response to antidepressants. Use of pattern analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Delayed onset of action of antidepressant drugs? Survey of recent results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Time course of improvement under antidepressant treatment: a survival-analytical approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300341

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300341

1 reference

Dimensions Publication ID

5 December 2017

1047826003

0 references

1 reference